Long-lasting HIV injection is a step closer after second GSK study

Long-lasting HIV injection is a step closer after second GSK study

Source: 
Reuters
snippet: 

A once-monthly injection to control HIV proved as effective as daily pills in a second study by GlaxoSmithKline, paving the way for a new regimen that could be simpler for some patients to be filed with regulators.